An observational study in Fatigue, Graft Vs Host Disease and Cognitive Dysfunction, sponsored by Karolinska University Hospital. Recruiting at 1 site in Sweden. Open to participants aged 20 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-26.
Sponsored by Karolinska University Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 43 studies in Fatigue with a site in Sweden — 14 open to participants now, 15 under way, none of them phase 3. Fatigue · Sweden.
Among the 43 studies in Fatigue with a site in Sweden, this one is the 13th largest by planned enrollment of the 15 observational ones that give a count, is one of 4 that started in 2023, is one of 15 observational ones, reaches primary completion later than 10 of the 14 other live ones, and was the 29th registered.
2,234 studies on the registry are indexed under Fatigue; 430 are open to participants now.
Browse Fatigue studies →14 of the 43 studies in Fatigue with a site in Sweden are open now. Recruiting first, the newest first:
The Swedish School of Sport and Health Sciences · Sites in Sweden
Ages 20–64
Karolinska Institutet · Sites in Sweden
Ages 18–67
Karolinska Institutet · Sites in Sweden
Ages 18+ · Healthy volunteers
Karolinska Institutet · Sites in Sweden
Ages 20–75
Karolinska Institutet · Sites in Sweden
Ages 18+
A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →
Of the 242 Fatigue studies recruiting now, 113 (47%) set no upper age limit and 99 (41%) stop at 75 or younger; 23 take children under 18; 74 take healthy volunteers.
This study: 20 Years to 75 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
43 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 4 started in 2023.
This study's planned enrollment of 30 is below the median of 99 across 406 observational studies indexed under Fatigue.
Median enrollment 70 across the 28 interventional studies, 100 across the 15 observational. Of the 27 that completed or were terminated, 1 (4%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 43 have an industry lead sponsor. The 10 most frequent:
Karolinska University Hospital is the lead sponsor of 279 studies on the registry; 55 are open to participants now.
Karolinska University Hospital has 3 studies filed under Fatigue — fewer than ten, so there is no comparison to draw.
2 of the studies in Fatigue with a site in Sweden that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06811948Blekinge County Council HospitalSleep-Disordered Breathing in the Acute Phase After Stroke and Neuropsychiatric Outcomes | 2027-05-20 |
| NCT06786832Karolinska InstitutetCharacterization, Treatment, and Long-term Follow-up of Fatigued Patients in Primary Care | 2027-06 |
Add all 2 to your calendar (.ics) → With an account.
Among the 43 studies in Fatigue with a site in Sweden, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Patients undergoing allogenic stem cell transplantation are regularly followed up in the outpatient clinic at Karolinska University Hospital. Here, patients are offered participation the fatigue study measuring both fatigue and cognitive impairment systematically by international standard. Meanwhile liquor samples and advanced PET imaging techniques are available for these patients as part of a research project allowing extensive immunological and radio-morphological studies.
Patients undergone allogeneic stemcell transplantation
Inclusion Criteria: PET images available retrospectively
Radiation: PET investigation
Radiation: PET investigation
Trial subjects will undergo two advanced PET investigations
To investigate the role of inflammation on synaptic density and glial cell activation as the cause of mental fatigue and cognitive dysfunction in survivors after alloSCT.
Analysis of PET imaging (both descriptive and radiokinetical) in combination with biological markers for neuroinflammation.
Time frame: 2024-2027
Plan to share: No
No publications or documents are linked to this record.
Started Nov 2023 (actual). Primary completion is estimated for Dec 2027, 49 months after the start.
Of 156 non-industry observational studies under Fatigue, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 45. This study's planned 49 months is above that.
Counting every sponsor, half of 166 studies reached it within 24 months; a quarter within 7 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Karolinska University Hospital →